Farm Com. 2022 Jun 15;14(Supl 1. Congreso SEFAC):237. doi: 10.33620/FC.2173-9218.(2022).CMC.250
Muriel J, Alonso M, Sánchez-Fuentes J, Chía B, Magariños M. Evidencia farmacogenética disponible de los subgrupos terapéuticos más consumidos en España. Farm Com. 2022 Jun 15;14(Supl 1. Congreso SEFAC):237. doi: 10.33620/FC.2173-9218.(2022).CMC.250
Última actualización de farmaceuticoscomunitarios.org : 14.06.2022
Copyright © 2012-2014 SEFAC (Sociedad Española de Farmacia Comunitaria) |
ISSN Digital edition: 2173-9218
Journal committees - Legal warning & Privaty policy - Cookies policy - Advertising policy
e-mail: soporte@sefac.org | Responsible for this web site: Jordi Serrano Valdés
Development, Web design & computer programming: Edittec |
We subscribe to
HONcode principles. Check it out here.
The information provided on this site is intended to complement and not to replace the
relation between a patient and his or her existing physician.
This work is under Creative Commons licence Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional licence.